The biochemical role of vitamin K in the post- translational modification of clotting factors is by?
**Core Concept**
Vitamin K plays a crucial role in the post-translational modification of clotting factors, specifically in the gamma-carboxylation of glutamic acid residues. This process is essential for the activation and stabilization of various vitamin K-dependent clotting factors, including prothrombin and factors II, VII, IX, and X. The gamma-carboxylation reaction is mediated by the enzyme vitamin K-dependent gamma-carboxylase.
**Why the Correct Answer is Right**
Gamma-carboxylation is a critical step in the activation of vitamin K-dependent clotting factors. During this process, the enzyme vitamin K-dependent gamma-carboxylase catalyzes the carboxylation of glutamic acid residues on the clotting factors, converting them into their active forms. This reaction is dependent on the presence of vitamin K, which serves as a cofactor. The vitamin K-dependent gamma-carboxylase uses vitamin K hydroquinone as a coenzyme to facilitate the carboxylation reaction.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe the biochemical role of vitamin K in the post-translational modification of clotting factors. While vitamin K is involved in the activation of clotting factors, it is not through the process of hydroxylation.
**Option B:** This option is incorrect because it is not specific to the biochemical role of vitamin K in the post-translational modification of clotting factors. Vitamin K-dependent clotting factors are indeed activated through a post-translational modification, but the correct mechanism is gamma-carboxylation, not phosphorylation.
**Option C:** This option is incorrect because it is not a recognized biochemical process involved in the activation of clotting factors. While protein folding is an important post-translational modification, it is not the mechanism by which vitamin K-dependent clotting factors are activated.
**Clinical Pearl / High-Yield Fact**
Warfarin, a common anticoagulant, inhibits vitamin K-dependent gamma-carboxylase, thereby preventing the activation of vitamin K-dependent clotting factors. This leads to a decrease in the production of active clotting factors, resulting in anticoagulation.
**Correct Answer:** C. gamma-carboxylation. Vitamin K-dependent gamma-carboxylation.